Henan Cancer Hospital

This phase 2 trial tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy (AVD) can improve outcomes for people with advanced classical Hodgkin lymphoma who have not yet been treated. About 60 adults aged 18 to 75 will receive the combination for up to …

This study tests whether the drug trilaciclib, given before chemotherapy, can prevent bone marrow suppression (low blood cell counts) in people with advanced non-small cell lung cancer. About 40 participants will receive trilaciclib before their platinum-based chemo. The main goa…

This phase II trial tests a combination of three drugs—fruquintinib, sintilimab, and SOX (S-1 plus oxaliplatin)—as a pre-surgery treatment for people with stage IV gastric cancer that cannot be fully removed. The goal is to shrink the tumor enough to allow complete surgical remov…